BioSpace News Archive

Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, announced the launch of Water for Injection and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada.

Inimmune announced today that its Chief Operating Officer, Dr. David Burkhart, will give a plenary presentation at the upcoming 17th Vaccine Congress in Glasgow, Scotland September 24-27th.

Breakthrough Properties, a premier global life sciences real estate developer, announced that it has reached an agreement with Neogene Therapeutics to develop its new European headquarters within the campus of the Amsterdam University Medical Center (Amsterdam UMC), one of Europe’s leading medical institutions.

Lehigh Valley Health Network and its subsidiaries, which include Lehigh Valley Reilly Children’s Hospital, and Children’s Hospital of Philadelphia announced an affiliation agreement that will enhance the care, health outcomes and well-being of families throughout the region.

C2N Diagnostics is marking World Alzheimer’s Day by highlighting the growing international availability of the PrecivityAD2 blood test, a clinical care assay that helps healthcare providers identify amyloid plaques in the brain, which are recognized as key indicators of Alzheimer’s disease.

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

Stryker, one of the world’s leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate.

Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of physicians, unite to pursue the creation of a new Board for cardiovascular medicine.

Today, at the Converge 2 Xcellerate (ConV2X) Symposium in New Orleans, Rymedi CEO David Stefanich and Chief Strategy Officer Jason Cross will speak about the application of blockchain technology and how the Rymedi platform is revolutionizing healthcare infrastructures on a global scale.

PHAXIAM Therapeutics, provides a business and financial update for the first half of 2023.